Biblio

Export 3139 results:
Author Title Type [ Year(Desc)]
2016
E. Magnin, Démonet, J. - F., Wallon, D., Dumurgier, J., Troussière, A. - C., Jager, A., Duron, E., Gabelle, A., de la Sayette, V., Volpe-Gillot, L., Tio, G., Evain, S., Boutoleau-Bretonnière, C., Enderle, A., Mouton-Liger, F., Robert, P., Hannequin, D., Pasquier, F., Hugon, J., and Paquet, C., “Primary Progressive Aphasia in the Network of French Alzheimer Plan Memory Centers.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1459-1471, 2016.
A. Trebbastoni, D'Antonio, F., de Lena, C., Onesti, E., John, B., and Inghilleri, M., “Primary Progressive Orofacial Apraxia: A Ten-Year Long Follow-Up Case Report.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1039-1045, 2016.
A. K. Tripathi and Singh, N., “Prion Protein-Hemin Interaction Upregulates Hemoglobin Synthesis: Implications for Cerebral Hemorrhage and Sporadic Creutzfeldt-Jakob Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 107-21, 2016.
E. Oldoni, Fumagalli, G. G., Serpente, M., Fenoglio, C., Scarioni, M., Arighi, A., Bruno, G., Talarico, G., Confaloni, A., Piscopo, P., Nacmias, B., Sorbi, S., Rainero, I., Rubino, E., Pinessi, L., Binetti, G., Ghidoni, R., Benussi, L., Grande, G., Arosio, B., Bursey, D., Kauwe, J. S., Cioffi, S. Mg, Arcaro, M., Mari, D., Mariani, C., Scarpini, E., and Galimberti, D., “PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population.”, J Alzheimers Dis, vol. 50, no. 2, pp. 353-7, 2016.
B. K. Binukumar, Pelech, S. L., Sutter, C., Shukla, V., Amin, N. D., Grant, P., Bhaskar, M., Skuntz, S., Steiner, J., and Pant, H. C., “Profiling of p5, a 24 Amino Acid Inhibitory Peptide Derived from the CDK5 Activator, p35 CDKR1 Against 70 Protein Kinases.”, J Alzheimers Dis, vol. 54, no. 2, pp. 525-33, 2016.
F. Bermejo-Pareja, Contador, I., Trincado, R., Lora, D., Sánchez-Ferro, Á., Mitchell, A. J., Boycheva, E., Herrero, A., Hernández-Gallego, J., Llamas, S., Galende, A. Villarejo, and Benito-León, J., “Prognostic Significance of Mild Cognitive Impairment Subtypes for Dementia and Mortality: Data from the NEDICES Cohort.”, J Alzheimers Dis, vol. 50, no. 3, pp. 719-31, 2016.
E. Morenas-Rodriguez, Cervera-Carles, L., Vilaplana, E., Alcolea, D., Carmona-Iragui, M., Dols-Icardo, O., Ribosa-Nogué, R., Muñoz-Llahuna, L., Sala, I., M Sánchez-Saudinós, B., Blesa, R., Clarimón, J., Fortea, J., and Lleo, A., “Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.”, J Alzheimers Dis, vol. 50, no. 2, pp. 539-46, 2016.
G. Tosto, Monsell, S. E., Hawes, S. E., Bruno, G., and Mayeux, R., “Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1085-93, 2016.
P. Paholpak, Li-Jung, L., Carr, D. R., Jimenez, E., Barrows, R. J., Sabodash, V., and Mendez, M. F., “Prolonged Visual Facial Grasp in Frontotemporal Dementia.”, J Alzheimers Dis, vol. 53, no. 1, pp. 327-35, 2016.
A. Naro, Corallo, F., De Salvo, S., Marra, A., Di Lorenzo, G., Muscarà, N., Russo, M., Marino, S., De Luca, R., Bramanti, P., and Calabrò, R. Salvatore, “Promising Role of Neuromodulation in Predicting the Progression of Mild Cognitive Impairment to Dementia.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1375-88, 2016.
N. Dermody, Hornberger, M., Piguet, O., Hodges, J. R., and Irish, M., “Prospective Memory Impairments in Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia: Clinical and Neural Correlates.”, J Alzheimers Dis, vol. 50, no. 2, pp. 425-41, 2016.
K. Bourgade, Le Page, A., Bocti, C., Witkowski, J. M., Dupuis, G., Frost, E. H., and Fülöp, T., “Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1227-41, 2016.
A. F. N. Rosenberger, Hilhorst, R., Coart, E., Barrado, L. García, Naji, F., Rozemuller, A. J. M., van der Flier, W. M., Scheltens, P., Hoozemans, J. J. M., and van der Vies, S. M., “Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 49, no. 4, pp. 927-43, 2016.
P. L. A. Leighton and W Allison, T., “Protein Misfolding in Prion and Prion-Like Diseases: Reconsidering a Required Role for Protein Loss-of-Function.”, J Alzheimers Dis, vol. 54, no. 1, pp. 3-29, 2016.
N. Gramunt, Sánchez-Benavides, G., Buschke, H., Lipton, R. B., Masramon, X., Gispert, J. D., Peña-Casanova, J., Fauria, K., and Molinuevo, J. L., “Psychometric Properties of the Memory Binding Test: Test-Retest Reliability and Convergent Validity.”, J Alzheimers Dis, vol. 50, no. 4, pp. 999-1010, 2016.
A. Jacquin-Piques, Sacco, G., Tavassoli, N., Rouaud, O., Bejot, Y., Giroud, M., Robert, P., Vellas, B., and Bonin-Guillaume, S., “Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.”, J Alzheimers Dis, vol. 49, no. 3, pp. 671-80, 2016.
X. - P. Hong, Chen, T., Yin, N. - N., Han, Y. - M., Yuan, F., Duan, Y. - J., Shen, F., Zhang, Y. - H., and Bin Chen, Z. -, “Puerarin Ameliorates D-Galactose Induced Enhanced Hippocampal Neurogenesis and Tau Hyperphosphorylation in Rat Brain.”, J Alzheimers Dis, vol. 51, no. 2, pp. 605-17, 2016.
X. Bengoetxea, de Cerain, A. López, Azqueta, A., and Ramirez, M. J., “Purported Interactions of Amyloid-β and Glucocorticoids in Cytotoxicity and Genotoxicity: Implications in Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1085-1094, 2016.
M. Maxime Lavallée, Gandini, D., Rouleau, I., Vallet, G. T., Joannette, M., Kergoat, M. - J., Busigny, T., Rossion, B., and Joubert, S., “A Qualitative Impairment in Face Perception in Alzheimer's Disease: Evidence from a Reduced Face Inversion Effect.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1225-36, 2016.
J. Ahdidan, Raji, C. A., DeYoe, E. A., Mathis, J., Noe, K. Ø., Rimestad, J., Kjeldsen, T. K., Mosegaard, J., Becker, J. T., and Lopez, O., “Quantitative Neuroimaging Software for Clinical Assessment of Hippocampal Volumes on MR Imaging.”, J Alzheimers Dis, vol. 49, no. 3, pp. 723-32, 2016.
J. C. Triplett, Swomley, A. M., Cai, J., Klein, J. B., and D Butterfield, A., “Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 45-62, 2016.
H. Wang, Wang, Y., Hong, X., Li, S., and Wang, Y., “Quantitative Proteomics Reveals the Mechanism of Oxygen Treatment on Lenses of Alzheimer's Disease Model Mice.”, J Alzheimers Dis, vol. 54, no. 1, pp. 275-86, 2016.
J. Carlos Cej Bolívar and Saladie, D. Gil, “Redefining Amnestic Mild Cognitive Impairment as an Early Form of Alzheimer's Disease Based on Assessment of Memory Systems.”, J Alzheimers Dis, vol. 53, no. 2, pp. 705-12, 2016.
S. Tholen, Schmaderer, C., Chmielewski, S., Förstl, H., Heemann, U., Baumann, M., Steubl, D., and Grimmer, T., “Reduction of Amyloid-β Plasma Levels by Hemodialysis: An Anti-Amyloid Treatment Strategy?”, J Alzheimers Dis, vol. 50, no. 3, pp. 791-6, 2016.
L. D. Estrada, Chamorro, D., Yañez, M. José, Gonzalez, M., Leal, N., von Bernhardi, R., Dulcey, A. E., Marugan, J., Ferrer, M., Soto, C., Zanlungo, S., Inestrosa, N. C., and Alvarez, A. R., “Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1193-1205, 2016.

Pages